Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Why do Most Phase III Clinical Trials Fail?

April 26, 2017clinical trials fail III phase

0

Posted

Why do Most Phase III Clinical Trials Fail?

1 Answer

0

Posted

Pp. 368-374 Pedro R. Lowenstein and Maria G. Castro [Abstract] [Purchase Article] [PMID: 19860651 PubMed – indexed for MEDLINE] Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinson’s Disease Pp. 375-388 Fredric P. Manfredsson, Michael S. Okun and Ronald J. Mandel [Abstract] [Purchase Article] [PMID: 19860652 PubMed – indexed for MEDLINE] Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy Pp. 389-395 Justin Kranzler, Matthew A. Tyler, Adam M. Sonabend, Ilya V. Ulasov and Maciej S. Lesniak [Abstract] [Purchase Article] [PMID: 19860653 PubMed – indexed for MEDLINE] Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes Pp. 396-408 Juan F. Vera, Malcolm K. Brenner and Gianpietro Dotti [Abstract] [Purchase Article] [PMID: 19860654 PubMed – indexed for MEDLINE] Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety Pp. 409-421 Marianela Candolfi, Kur